UNSPSC 51291500: Antidepressant azoles

Antidepressant drugs made from five membered rings containing a nitrogen atom.

UNSPSC 51291500 Antidepressant azoles is a Class code that in current state and local procurement activity encompasses a much broader scope than its nominal category suggests. Recent solicitations reveal that state and local buyers are acquiring naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products through formal bidding and cooperative purchasing mechanisms. The issuing bodies include county health departments, state health and human services agencies, and multistate cooperative purchasing alliances. Seminole County, Florida is pursuing naloxone and drug deactivation system procurement, while the Texas Health and Human Services Commission is exploring direct-to-manufacturer pharmacy initiatives, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) is managing a broad generic pharmaceutical and OTC product contract covering multiple states. Work solicited under this code ranges from annual bulk purchases of specific pharmaceutical products delivered quarterly to exploration of alternative supply-chain models that bypass traditional pharmacy benefit managers and group purchasing organizations.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline and quarterly deliveries to the Seminole County Community Health Building. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program with no formal deadline structure. The Minnesota Multistate Cooperative Purchasing Alliance released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026, and contract effectiveness set for July 1, 2026. The MMCAP procurement requires vendors to work through three authorized wholesalers and mandates compliance with cGMP and the Drug Supply Chain Security Act, with pricing evaluated at 75 percent weight and administrative fees set at 3 percent of contract purchases.